LLY

776.45

-2.39%↓

JNJ

152.33

+0.12%↑

ABBV

182.26

-2.5%↓

NVO

68.53

+1.17%↑

UNH

308.74

+2.11%↑

LLY

776.45

-2.39%↓

JNJ

152.33

+0.12%↑

ABBV

182.26

-2.5%↓

NVO

68.53

+1.17%↑

UNH

308.74

+2.11%↑

LLY

776.45

-2.39%↓

JNJ

152.33

+0.12%↑

ABBV

182.26

-2.5%↓

NVO

68.53

+1.17%↑

UNH

308.74

+2.11%↑

LLY

776.45

-2.39%↓

JNJ

152.33

+0.12%↑

ABBV

182.26

-2.5%↓

NVO

68.53

+1.17%↑

UNH

308.74

+2.11%↑

LLY

776.45

-2.39%↓

JNJ

152.33

+0.12%↑

ABBV

182.26

-2.5%↓

NVO

68.53

+1.17%↑

UNH

308.74

+2.11%↑

Search

Assembly Biosciences Inc

Closed

SectorHealthcare

17.04 0.29

Overview

Share price change

24h

Current

Min

16.49

Max

17.31

Recommendations

By TipRanks

Recommendations

Buy

12 Months Forecast

+69.79% upside

Dividends

By Dow Jones

Next Earnings

6 sie 2025

News Sentiment

By Acuity

15%

85%

25 / 380 Ranking in Healthcare

Technical Score

By Trading Central

Confidence

Neutral Evidence

Assembly Biosciences Inc Chart

Wyniki osiągnięte w przeszłości nie są gwarantem przyszłych wyników.

Related News

19 gru 2024, 15:25 UTC

Major Market Movers

Assembly Biosciences Shares Rise 19% After Gilead Investment, Funding

19 gru 2024, 13:38 UTC

Major Market Movers

Assembly Biosciences Gets $30.1 Million Equity Investment, Funding From Gilead

29 gru 2024, 08:00 UTC

Acquisitions, Mergers, Takeovers

Gilead Buys $20.1 Million of Assembly Biosciences Stock -- Barrons.com

19 gru 2024, 13:23 UTC

Major Market Movers

Assembly Biosciences Gets $30.1M Equity Investment, Funding From Gilead

Peer Comparison

Price change

Assembly Biosciences Inc Forecast

Price Target

By TipRanks

69.79% upside

12 Months Forecast

Average 29 USD  69.79%

High 29 USD

Low 29 USD

Based on 1 Wall Street analysts offering 12 month price targets forAssembly Biosciences Inc - Dist in the last 3 months.

Rating Consensus

By TipRanks

Buy

1 ratings

1

Buy

0

Hold

0

Sell

Technical Score

By Trading Central

11.39 / 14.13Support & Resistance

Short Term

Neutral Evidence

Intermediate Term

Strong Bullish Evidence

Long Term

Bearish Evidence

Sentiment

By Acuity

25 / 380 Ranking in Healthcare

News Sentiment

Very Strong Bullish Evidence

Volatility

Below average

News Volume (RCV)

Above average

Financials

$